Sumitomo Mitsui Trust Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-63,550
| Closed | -$850K | – | 1064 |
|
2024
Q2 | $850K | Sell |
63,550
-1,333,076
| -95% | -$17.8M | ﹤0.01% | 917 |
|
2024
Q1 | $64.8M | Sell |
1,396,626
-59,347
| -4% | -$2.75M | 0.04% | 420 |
|
2023
Q4 | $98.4M | Sell |
1,455,973
-12,681
| -0.9% | -$857K | 0.07% | 289 |
|
2023
Q3 | $106M | Buy |
1,468,654
+198,965
| +16% | +$14.4M | 0.09% | 241 |
|
2023
Q2 | $94.5M | Buy |
1,269,689
+204,774
| +19% | +$15.2M | 0.07% | 293 |
|
2023
Q1 | $56.7M | Buy |
1,064,915
+127,057
| +14% | +$6.76M | 0.04% | 456 |
|
2022
Q4 | $63.4M | Buy |
937,858
+163,309
| +21% | +$11M | 0.05% | 428 |
|
2022
Q3 | $96.7M | Buy |
774,549
+228,095
| +42% | +$28.5M | 0.08% | 296 |
|
2022
Q2 | $52M | Buy |
+546,454
| New | +$52M | 0.04% | 494 |
|
2022
Q1 | – | Sell |
-282,675
| Closed | -$94M | – | 1192 |
|
2021
Q4 | $94M | Buy |
282,675
+168,858
| +148% | +$56.1M | 0.06% | 360 |
|
2021
Q3 | $52.8M | Buy |
+113,817
| New | +$52.8M | 0.03% | 534 |
|